← FDA Drug Approvals (Drugs@FDA)

TELMISARTAN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PRINSTON INC · Approved 2017-05-03

Drug application

FDA Application #
ANDA207882
Application type
Abbreviated New Drug Application (Generic)
Brand name
TELMISARTAN
Generic name
TELMISARTAN
Active ingredients
TELMISARTAN
Dosage form
TABLET
Route
ORAL
Marketing status
Prescription
Sponsor
PRINSTON INC
Manufacturer
Solco Healthcare US, LLC
First approval
2017-05-03

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown